Carolina Biooncology Institute Huntersville, NC - 28078

Carolina Biooncology Institute is categorized under Doctors in Huntersville, NC and active since 2005.

Carolina Biooncology Institute was established in 2005, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact John Powderly, Owner at the company’s single location by writing to 9801 Kincey Avenue # 145, Huntersville, North Carolina NC 28078 or by phoning (704) 947-6599. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Carolina Biooncology Institute
Contact Person: John Powderly, Owner
Address: 9801 Kincey Avenue # 145, Huntersville, North Carolina 28078
Phone Number: (704) 947-6599
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Carolina Biooncology Institute was started in 2005 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact John Powderly, Owner for inquiries that concern Carolina Biooncology Institute by calling the company number (704) 947-6599, as your correspondence is most welcome. Additionally, the physical location of the single location of Carolina Biooncology Institute can be found at the coordinates 35.404121,-80.864153 as well as the street address 9801 Kincey Avenue # 145 in Huntersville, North Carolina 28078.

For its online presence, you may visit Carolina Biooncology Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.